US20030144476A1
(en)
*
|
2000-03-06 |
2003-07-31 |
Pankaj Agarwal |
Novel compounds
|
EP1666497A3
(en)
*
|
2000-06-02 |
2006-06-21 |
Genentech, Inc. |
Polypeptide, nucleic acid encoding it, and their use for the diagnosis of cancer
|
AU6531101A
(en)
*
|
2000-06-02 |
2001-12-17 |
Genentech Inc |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
EP1294888B1
(en)
*
|
2000-06-30 |
2007-04-25 |
ZymoGenetics, Inc. |
Interferon-like protein zcyto21
|
US20040254348A1
(en)
*
|
2000-07-12 |
2004-12-16 |
Shuji Hinuma |
Novel polypeptide and dna thereof
|
CA2420392A1
(en)
*
|
2000-08-28 |
2002-03-07 |
Human Genome Sciences, Inc. |
17 human secreted proteins
|
JP4503801B2
(en)
*
|
2000-09-08 |
2010-07-14 |
独立行政法人科学技術振興機構 |
Novel human cancer / testis antigen and its gene
|
WO2002052005A1
(en)
|
2000-12-22 |
2002-07-04 |
Kazusa Dna Research Institute Foundation |
Novel genes and proteins encoded thereby
|
JPWO2002061076A1
(en)
*
|
2001-02-01 |
2004-06-03 |
持田製薬株式会社 |
Adiponectin-related protein
|
WO2002074906A2
(en)
*
|
2001-03-16 |
2002-09-26 |
Eli Lilly And Company |
Lp mammalian proteins; related reagents
|
AU2002306879A1
(en)
*
|
2001-03-29 |
2002-10-15 |
Incyte Genomics, Inc. |
Cytoskeleton-associated proteins
|
WO2002083068A2
(en)
*
|
2001-04-10 |
2002-10-24 |
Agensys, Inc. |
Nucleic acid and corresponding protein entitled 121p2a3 useful in treatment and detection of cancer
|
US7309760B2
(en)
|
2001-04-17 |
2007-12-18 |
The Board Of Trustees Of The University Of Arkansas |
Repeat sequences of the CA125 gene and their use for diagnostic and therapeutic interventions
|
WO2002088312A2
(en)
*
|
2001-04-26 |
2002-11-07 |
Pe Corporation (Ny) |
Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
|
AUPR470101A0
(en)
*
|
2001-05-02 |
2001-05-24 |
Murdoch Childrens Research Institute, The |
A molecular marker
|
CA2445781A1
(en)
*
|
2001-05-03 |
2002-11-14 |
Akzo Nobel N.V. |
Peptidylarginine deiminase 6
|
US7157558B2
(en)
|
2001-06-01 |
2007-01-02 |
Genentech, Inc. |
Polypeptide encoded by a polynucleotide overexpresses in tumors
|
US20050085627A1
(en)
|
2001-06-21 |
2005-04-21 |
Youming Zhang |
Atopy
|
US7314725B2
(en)
|
2001-07-20 |
2008-01-01 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Phenylthiocarbamide (PTC) taste receptor
|
US7833779B2
(en)
|
2001-07-25 |
2010-11-16 |
Jivan Biologies Inc. |
Methods and systems for polynucleotide detection
|
US7340349B2
(en)
|
2001-07-25 |
2008-03-04 |
Jonathan Bingham |
Method and system for identifying splice variants of a gene
|
EP1423415A4
(en)
*
|
2001-08-17 |
2005-04-06 |
Incyte Genomics Inc |
Intracellular signaling molecules
|
CA2458648A1
(en)
*
|
2001-08-17 |
2003-02-27 |
Incyte Genomics, Inc. |
Secreted proteins
|
US7198912B2
(en)
|
2001-09-07 |
2007-04-03 |
Bristol-Myers Squibb Company |
Polynucleotides encoding a human G-protein coupled receptor, HGPRBMY39
|
US20040253597A1
(en)
*
|
2001-09-17 |
2004-12-16 |
Atsushi Nakanishi |
Novel protein and dna thereof
|
CA2461065A1
(en)
|
2001-09-19 |
2003-03-27 |
The Government Of The United States Of America |
Transductin-1 and transductin-2 and applications to hereditary deafness
|
US7504222B2
(en)
|
2001-10-31 |
2009-03-17 |
Millennium Pharmaceuticals, Inc. |
Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
|
US20040197778A1
(en)
*
|
2002-12-26 |
2004-10-07 |
Sagres Discovery, Inc. |
Novel compositions and methods in cancer
|
US8124052B2
(en)
*
|
2003-02-10 |
2012-02-28 |
Georgetown University |
Method for identifying targeting domains and methods and compositions comprising the same
|
WO2003072035A2
(en)
*
|
2002-02-22 |
2003-09-04 |
Genentech, Inc. |
Compositions and methods for the treatment of immune related diseases
|
EP1506215B1
(en)
*
|
2002-03-05 |
2016-11-30 |
Genentech, Inc. |
Novel polypeptides having sequence similarity to gdnfr and nucleic acids encoding the same
|
US7576185B2
(en)
|
2002-03-05 |
2009-08-18 |
Genentech, Inc. |
PRO34128 antibodies
|
DE10211088A1
(en)
|
2002-03-13 |
2003-09-25 |
Ugur Sahin |
Gene products differentially expressed in tumors and their use
|
EP3115470B1
(en)
|
2002-03-13 |
2018-07-18 |
Genomic Health, Inc. |
Gene expression profiling in biopsied tumor tissues
|
US7223580B2
(en)
*
|
2002-03-14 |
2007-05-29 |
National Institute Of Advanced Industrial Science And Technology |
N-acetylglucosamine transferase, nucleic acid encoding the same and use thereof in diagnosing cancer and/or tumor
|
CA2483436A1
(en)
*
|
2002-04-23 |
2003-11-06 |
University Of Georgia Research Foundation, Inc. |
N-acetylglucosaminyltransferase vb coding sequence, recombinant cells and methods
|
AU2003269880A1
(en)
*
|
2002-05-21 |
2003-12-22 |
Dendreon Corporation |
Nucleic acid molecules encoding a transmembrane serine protease 12, the encoded polypeptides and methods based thereon
|
WO2003101401A2
(en)
|
2002-06-03 |
2003-12-11 |
Chiron Corporation |
Use of nrg4, or inhibitors thereof, in the treatment of colon and pancreatic cancer
|
JP2006515157A
(en)
|
2002-07-29 |
2006-05-25 |
セノミックス、インコーポレイテッド |
Identification of a novel bitter taste receptor T2R76
|
WO2004013347A2
(en)
*
|
2002-08-06 |
2004-02-12 |
Curagen Corporation |
Methods of identifying compounds that modulate protein activity
|
AU2003256074B2
(en)
*
|
2002-08-14 |
2011-02-03 |
National Institute Of Advanced Industrial Science And Technology |
Novel N-acetylgalactosamine transferases and nucleic acids encoding the same
|
CA2498771A1
(en)
*
|
2002-09-13 |
2004-03-25 |
Sankyo Company Limited |
2',5'-oligoadenylate phosphodiesterase
|
CA2498274A1
(en)
*
|
2002-09-16 |
2004-03-25 |
Genentech, Inc. |
Compositions and methods for the diagnosis of immune related diseases using pro7
|
WO2004028342A2
(en)
*
|
2002-09-25 |
2004-04-08 |
Board Of Regents, The University Of Texas System |
Endogenous granzyme b in human non-hematopoietic cells
|
US7700108B2
(en)
*
|
2002-09-27 |
2010-04-20 |
Dainippon Sumitomo Pharma Co., Ltd. |
Tumor antigen protein and use thereof
|
CN1703524B
(en)
|
2002-09-30 |
2010-04-07 |
肿瘤疗法科学股份有限公司 |
Genes and polypeptides relating to human pancreatic cancer
|
EP1558737A4
(en)
*
|
2002-10-18 |
2008-06-11 |
Lg Life Sciences Ltd |
Gene families associated with cancers
|
GB0224436D0
(en)
*
|
2002-10-21 |
2002-11-27 |
Univ Cambridge Tech |
Polypetides methods and means
|
EP2322203A3
(en)
*
|
2002-10-29 |
2011-07-27 |
Genentech, Inc. |
Compositions and methods for the treatment of immune related diseases
|
US7288642B1
(en)
*
|
2002-11-07 |
2007-10-30 |
Mayo Foundation For Medical Education And Research |
Sulfotransferase 2B1 pharmacogenetics
|
JP4606879B2
(en)
|
2002-11-15 |
2011-01-05 |
ジェノミック ヘルス, インコーポレイテッド |
Gene expression profiling of EGFR positive cancer
|
DE10254601A1
(en)
|
2002-11-22 |
2004-06-03 |
Ganymed Pharmaceuticals Ag |
Gene products differentially expressed in tumors and their use
|
GB0227908D0
(en)
*
|
2002-11-29 |
2003-01-08 |
Univ London |
Cancer related methods and means
|
US20040231909A1
(en)
|
2003-01-15 |
2004-11-25 |
Tai-Yang Luh |
Motorized vehicle having forward and backward differential structure
|
AU2007231823B2
(en)
*
|
2003-01-24 |
2011-07-21 |
Agensys, Inc. |
Nucleic acids and corresponding proteins entitled 254P1D6B useful in treatment and detection of cancer
|
CA2514058C
(en)
*
|
2003-01-24 |
2014-05-13 |
Agensys, Inc. |
Nucleic acids and corresponding proteins entitled 254p1d6b useful in treatment and detection of cancer
|
US20080107600A1
(en)
*
|
2003-02-13 |
2008-05-08 |
Taiichi Katayama |
Gene Marker And Composition For Diagnosis And Treatment Of Neurological Disorders And Diseases And Use Of The Same
|
JP4568716B2
(en)
|
2003-02-20 |
2010-10-27 |
ジェノミック ヘルス, インコーポレイテッド |
Use of intron RNA to measure gene expression
|
US7312197B2
(en)
|
2003-02-24 |
2007-12-25 |
University Of Maryland, Baltimore |
Method of modifying glucose activity using polypeptides selectively expressed in fat tissue
|
WO2004081170A2
(en)
*
|
2003-03-10 |
2004-09-23 |
Ares Trading S.A. |
Progestin receptor-like protein
|
RS54160B1
(en)
|
2003-03-19 |
2015-12-31 |
Biogen Idec Ma Inc. |
Nogo receptor binding protein
|
ITRM20030149A1
(en)
|
2003-04-02 |
2004-10-03 |
Giuliani Spa |
ANTISENSE OLIGONUCLEOTIDES (ODN) FOR SMAD7 AND THEIR USE IN THE MEDICAL FIELD
|
WO2004087748A1
(en)
*
|
2003-04-04 |
2004-10-14 |
Centre National De La Recherche Scientifique |
Protein with fusogenic activity, nucleic acid sequences encoding said protein and pharmaceutical compositions comprising the same
|
US7306910B2
(en)
|
2003-04-24 |
2007-12-11 |
Veridex, Llc |
Breast cancer prognostics
|
FR2854640A1
(en)
*
|
2003-05-07 |
2004-11-12 |
Galderma Res & Dev |
Use of polynucleotide probe specific for the PMP 69 gene in diagnosis of psoriasis and to screen for antipsoriatic agents, also therapeutic use by inhibiting PMP 69 expression or activity
|
WO2004111273A2
(en)
*
|
2003-05-30 |
2004-12-23 |
Genomic Health, Inc. |
Gene expression markers for response to egfr inhibitor drugs
|
US7579453B2
(en)
|
2003-06-19 |
2009-08-25 |
The United States Of America As Represented By The Secretary Of The Dapartment Of Health And Human Services |
Variants of human taste receptor genes
|
EP3470535B1
(en)
|
2003-06-24 |
2020-04-01 |
Genomic Health, Inc. |
Prediction of likelihood of cancer recurrence
|
WO2005044977A2
(en)
*
|
2003-06-25 |
2005-05-19 |
Diadexus, Inc. |
Compositions, splice variants and methods relating to lung specific genes and proteins
|
JPWO2005001089A1
(en)
*
|
2003-06-27 |
2006-11-02 |
生化学工業株式会社 |
Cancer detection method
|
WO2005008213A2
(en)
|
2003-07-10 |
2005-01-27 |
Genomic Health, Inc. |
Expression profile algorithm and test for cancer prognosis
|
DE10332854A1
(en)
*
|
2003-07-18 |
2005-02-17 |
Universitätsklinikum der Charité der Humboldt-Universität zu Berlin |
Use of the newly identified human gene 7a5 / prognostin for tumor diagnostics and tumor therapy
|
US20070037204A1
(en)
|
2003-08-08 |
2007-02-15 |
Hiroyuki ABURANTAI |
Gene overexpressed in cancer
|
EP2311468B1
(en)
*
|
2003-08-08 |
2014-01-15 |
Perseus Proteomics Inc. |
Gene overexpressed in cancer
|
WO2005019255A1
(en)
*
|
2003-08-25 |
2005-03-03 |
Pieris Proteolab Ag |
Muteins of tear lipocalin
|
CA2475769C
(en)
*
|
2003-08-28 |
2018-12-11 |
Veridex, Llc |
Colorectal cancer prognostics
|
PL1668152T3
(en)
*
|
2003-08-28 |
2009-06-30 |
Ipsogen |
Identification of an erbb2 gene expression signature in breast cancer
|
DE10341812A1
(en)
*
|
2003-09-10 |
2005-04-07 |
Ganymed Pharmaceuticals Ag |
Differentially expressed in tumors gene products and their use
|
DE10345010A1
(en)
*
|
2003-09-22 |
2005-04-28 |
Eike Staub |
Use of the receptor Nifie14, or nucleic acid encoding it, for detecting cancer, or the risk of developing it, also use of Nifie 14 binding agents for diagnosis and treatment of cancer
|
DE10344799A1
(en)
|
2003-09-26 |
2005-04-14 |
Ganymed Pharmaceuticals Ag |
Identification of surface-associated antigens for tumor diagnosis and therapy
|
GB0322998D0
(en)
*
|
2003-10-01 |
2003-11-05 |
Ares Trading Sa |
Protein
|
WO2005051994A2
(en)
*
|
2003-11-21 |
2005-06-09 |
Zymogenetics, Inc. |
Ztnf11, a tumor necrosis factor
|
CA3050151C
(en)
*
|
2003-11-26 |
2023-03-07 |
Celera Corporation |
Single nucleotide polymorphisms associated with cardiovascular disorders and statin response, methods of detection and uses thereof
|
WO2005052154A1
(en)
*
|
2003-11-27 |
2005-06-09 |
Takeda Pharmaceutical Company Limited |
Method of estimating toxicity of drug
|
AU2004294527A1
(en)
*
|
2003-12-05 |
2005-06-16 |
Erasmus Mc |
Predicting response and outcome of metastatic breast cancer anti-estrogen therapy
|
WO2005064019A2
(en)
|
2003-12-23 |
2005-07-14 |
Genomic Health, Inc. |
Universal amplification of fragmented rna
|
WO2005066363A2
(en)
*
|
2004-01-09 |
2005-07-21 |
Medigen Biotechnology Corporation |
Cancer specific gene ccndbp1
|
WO2005076014A1
(en)
*
|
2004-01-28 |
2005-08-18 |
Bayer Healthcare Ag |
Diagnostics and therapeutics for diseases associated with human metabotropic glutamate receptor 2 (mglur2)
|
EP1711633A1
(en)
*
|
2004-02-04 |
2006-10-18 |
EVOTEC Neurosciences GmbH |
Diagnostic and therapeutic use of the kcne4 gene and protein for alzheimer disease
|
JP5830213B2
(en)
*
|
2004-02-17 |
2015-12-09 |
ザ ホスピタル フォー シック チルドレン |
MECP2E1 gene
|
US8637236B2
(en)
|
2004-02-17 |
2014-01-28 |
The Hospital For Sick Children |
MECP2E1 gene
|
WO2005078444A1
(en)
*
|
2004-02-18 |
2005-08-25 |
Bayer Healthcare Ag |
Diagnostics and therapeutics for diseases associated with human melatonin receptor type 1b (mtnr1b)
|
WO2005083437A1
(en)
*
|
2004-02-26 |
2005-09-09 |
Bayer Healthcare Ag |
Diagnostics and therapeutics for diseases associated with integrin-linked kinase 2 (ilk2)
|
US7166433B2
(en)
*
|
2004-03-03 |
2007-01-23 |
The United States Of America As Represented By The Department Of Health And Human Services |
Transductin-1 and transductin-2 and applications to hereditary deafness
|
AU2005223847A1
(en)
|
2004-03-19 |
2005-09-29 |
Yale University |
Detection, isolation and uses of renalase (Monoamine Oxidase C)
|
WO2005090569A1
(en)
*
|
2004-03-24 |
2005-09-29 |
The Council Of The Queensland Institute Of Medical Research |
Cancer and testis vsm1 and vsm2 nucleic acids, proteins and uses thereof
|
US7667013B2
(en)
*
|
2004-03-31 |
2010-02-23 |
Daiichi Sankyo Company, Limited |
Gene encoding a guanine nucleotide exchange factor and the gene product thereof
|
ES2550614T3
(en)
|
2004-04-09 |
2015-11-11 |
Genomic Health, Inc. |
Gene expression markers to predict the response to chemotherapy
|
WO2005103713A2
(en)
|
2004-04-20 |
2005-11-03 |
Galapagos N.V. |
Methods, compositions and compound assays for inhibiting amyloid-beta protein production
|
HUE039448T2
(en)
|
2004-04-21 |
2018-12-28 |
Alexion Pharma Inc |
Bone delivery conjugates and method of using same to target proteins to bone
|
US20070286854A1
(en)
|
2004-04-28 |
2007-12-13 |
Bayer Healthcare Ag |
Diagnostics And Therapeutics For Diseases Associated With Dipeptidyl-Peptidase 1 (Dpp1)
|
DE102004024617A1
(en)
|
2004-05-18 |
2005-12-29 |
Ganymed Pharmaceuticals Ag |
Differentially expressed in tumors gene products and their use
|
EP1766042A2
(en)
*
|
2004-05-21 |
2007-03-28 |
Bayer HealthCare AG |
Diagnostics and therapeutics for diseases associated with chymase (cma1)
|
EP1751188A1
(en)
*
|
2004-06-04 |
2007-02-14 |
Applied Research Systems ARS Holding N.V. |
Splice variant of unc5h2
|
US20070081984A1
(en)
|
2005-10-11 |
2007-04-12 |
Shunji Tomatsu |
Compositions and methods for treating hypophosphatasia
|
US8034553B2
(en)
*
|
2004-06-24 |
2011-10-11 |
Kimberly-Clark Worldwide, Inc. |
Biomarkers for wound healing
|
CA2572193A1
(en)
|
2004-06-24 |
2006-01-05 |
Biogen Idec Ma Inc. |
Treatment of conditions involving oligodendrocytes with sp35 based agents
|
US7587279B2
(en)
|
2004-07-06 |
2009-09-08 |
Genomic Health |
Method for quantitative PCR data analysis system (QDAS)
|
US20060008876A1
(en)
|
2004-07-07 |
2006-01-12 |
Shami A S E |
ME-5, ME-2, and EPP2: human protein antigens reactive with autoantibodies present in the serum of women suffering from endometriosis
|
WO2006012451A2
(en)
*
|
2004-07-22 |
2006-02-02 |
Five Prime Therapeutics, Inc. |
Compositions and methods of use for mgd-csf in disease treatment
|
WO2006010516A1
(en)
*
|
2004-07-29 |
2006-02-02 |
Bayer Healthcare Ag |
Diagnostics and therapeutics for diseases associated with methionine aminopeptidase 2 like protein (metap2-like)
|
WO2006022689A1
(en)
*
|
2004-08-06 |
2006-03-02 |
Applera Corporation |
Method and compositions for treating diseases targeting cd51
|
GB0417887D0
(en)
|
2004-08-11 |
2004-09-15 |
Ares Trading Sa |
Protein
|
WO2006052731A2
(en)
|
2004-11-05 |
2006-05-18 |
Genomic Health, Inc. |
Molecular indicators of breast cancer prognosis and prediction of treatment response
|
CA3061785A1
(en)
|
2004-11-05 |
2006-05-18 |
Genomic Health, Inc. |
Predicting response to chemotherapy using gene expression markers
|
WO2007011412A2
(en)
*
|
2004-11-05 |
2007-01-25 |
The Government Of The United States Of America, As Represented By The Secretary Of The Navy |
Diagnosis and prognosis of infectious diesease clinical phenotypes and other physiologic states using host gene expresion biomarkers in blood
|
DE602006014659D1
(en)
*
|
2005-02-02 |
2010-07-15 |
Eisai R&D Man Co Ltd |
METHOD FOR IDENTIFYING PURKINJE CELLS USING THE CORL2 GENE AS A TARGET
|
WO2006090389A2
(en)
|
2005-02-24 |
2006-08-31 |
Compugen Ltd. |
Novel diagnostic markers, especially for in vivo imaging, and assays and methods of use thereof
|
DE102005013846A1
(en)
*
|
2005-03-24 |
2006-10-05 |
Ganymed Pharmaceuticals Ag |
Identification of surface-associated antigens for tumor diagnosis and therapy
|
EP2238986A3
(en)
|
2005-07-08 |
2010-11-03 |
Biogen Idec MA Inc. |
Sp35 antibodies and uses thereof
|
GB0515180D0
(en)
*
|
2005-07-22 |
2005-08-31 |
Ares Trading Sa |
Protein
|
EP1926747A1
(en)
|
2005-08-12 |
2008-06-04 |
Schering Corporation |
Mcp1 fusions
|
WO2007056674A2
(en)
*
|
2005-11-02 |
2007-05-18 |
Stowers Institute For Medical Research |
Novel nucleic acids and associated diagnostics
|
CA2630085A1
(en)
|
2005-11-21 |
2007-05-24 |
Yale University |
Methods of regulating renalase (monoamine oxidase c)
|
EP1790664A1
(en)
|
2005-11-24 |
2007-05-30 |
Ganymed Pharmaceuticals AG |
Monoclonal antibodies against claudin-18 for treatment of cancer
|
GB0524648D0
(en)
*
|
2005-12-02 |
2006-01-11 |
Ares Trading Sa |
Reeler domain containing protein
|
GB0524984D0
(en)
*
|
2005-12-07 |
2006-01-18 |
Ares Trading Sa |
Cys-rich, cell surface glycoproteins
|
GB0525958D0
(en)
*
|
2005-12-20 |
2006-02-01 |
Ares Trading Sa |
Casein-like secreted protein
|
WO2008054534A2
(en)
|
2006-05-11 |
2008-05-08 |
Quark Pharmaceuticals, Inc. |
Screening systems utilizing rtp801
|
EP2026843A4
(en)
|
2006-06-09 |
2011-06-22 |
Quark Pharmaceuticals Inc |
Therapeutic uses of inhibitors of rtp801l
|
GB0611405D0
(en)
*
|
2006-06-09 |
2006-07-19 |
Univ Belfast |
FKBP-L: A novel inhibitor of angiogenesis
|
SI2044111T1
(en)
|
2006-06-21 |
2015-02-27 |
Musc Foundation For Research Development |
Targeting complement factor h for treatment of diseases
|
KR100873382B1
(en)
|
2006-12-21 |
2008-12-10 |
김현기 |
Human protooncogene, protein encoded by same, expression vector containing same, and cell transformed by said vector
|
US8128926B2
(en)
|
2007-01-09 |
2012-03-06 |
Biogen Idec Ma Inc. |
Sp35 antibodies and uses thereof
|
US20120070444A1
(en)
*
|
2007-01-19 |
2012-03-22 |
Probiodrug Ag |
IN VIVO SCREENING MODELS FOR TREATMENT OF isoQC-RELATED DISORDERS
|
AU2008222580A1
(en)
*
|
2007-03-07 |
2008-09-12 |
The Council Of The Queensland Institute Of Medical Research |
Novel human ssDNA binding proteins and methods of cancer diagnosis
|
US8614311B2
(en)
|
2007-12-12 |
2013-12-24 |
Quark Pharmaceuticals, Inc. |
RTP801L siRNA compounds and methods of use thereof
|
WO2009097351A2
(en)
|
2008-01-28 |
2009-08-06 |
The Board Of Regents Of The University Of Texas System |
TAK1-D MEDIATED INDUCTION OF CELL DEATH IN HUMAN CANCER CELLS BY SPECIFIC SEQUENCE SHORT DOUBLE STRANDED RNAs
|
US7879553B2
(en)
|
2008-03-14 |
2011-02-01 |
Exagen Diagnostics, Inc. |
Biomarkers for inflammatory bowel disease and irritable bowel syndrome
|
US20110294682A1
(en)
*
|
2008-04-28 |
2011-12-01 |
The General Hospital Corporation |
Polynucleotides Associated With Age-Related Macular Degeneration and Methods for Evaluating Patient Risks
|
EP2133433A1
(en)
*
|
2008-06-09 |
2009-12-16 |
Centre Georges François Leclerc |
A method for predicting responsiveness to a treatment with an anti-HER2 antibody
|
JP5726729B2
(en)
*
|
2008-06-25 |
2015-06-03 |
インスティチュート・パスツール・コリアInstitut Pasteur Korea |
Genome-wide visual identification of human cofactors for HIV-1 infection
|
AU2009269099B2
(en)
|
2008-07-09 |
2016-03-10 |
Biogen Ma Inc. |
Compositions comprising antibodies to LINGO or fragments thereof
|
WO2010022145A2
(en)
*
|
2008-08-19 |
2010-02-25 |
The University Of North Carolina At Chapel Hill |
Alternatively-spliced isoform of mu-opioid receptor gene with cell excitatory function
|
KR101061016B1
(en)
|
2008-09-17 |
2011-08-31 |
강원대학교산학협력단 |
Polypeptides or fusion proteins thereof having an inhibitory activity against growth of cancer cells and preventive or treating activity against inflammatory diseases
|
KR101062167B1
(en)
*
|
2008-10-23 |
2011-09-05 |
사회복지법인 삼성생명공익재단 |
A composition for treating cancer comprising a Vir 2.2 inhibitor
|
WO2010092974A1
(en)
*
|
2009-02-11 |
2010-08-19 |
国立大学法人東京大学 |
Brain tumor stem cell differentiation promoter, and therapeutic agent for brain tumor
|
DK3255146T3
(en)
|
2009-03-16 |
2019-08-19 |
Pangu Biopharma Ltd |
Compositions and Methods comprising Histidyl-tRNA Synthetase Splicing Variants with Non-Canonical Biological Activities
|
US8268550B2
(en)
*
|
2009-06-26 |
2012-09-18 |
Massachusetts Institute Of Technology |
Compositions and methods for identification of PARP function, inhibitors, and activators
|
US8435961B2
(en)
|
2009-06-26 |
2013-05-07 |
Massachusetts Institute Of Technology |
Methods and compositions for increasing the activity of inhibitory RNA
|
US20110097329A1
(en)
|
2009-06-26 |
2011-04-28 |
Massachusetts Institute Of Technology |
Compositions and methods for treating cancer and modulating stress granule formation
|
RS20120461A1
(en)
|
2009-07-02 |
2013-06-28 |
Musc Foundation For Research Development |
Methods of stimulating liver regeneration
|
KR20120130748A
(en)
|
2009-11-05 |
2012-12-03 |
알렉시온 캠브리지 코포레이션 |
Treatment of paroxysmal nocturnal hemoglobinuria, hemolytic anemias and disease states involving intravascular and extravascular hemolysis
|
EP2509625B1
(en)
|
2009-12-11 |
2015-01-28 |
Atyr Pharma, Inc. |
Histidyl trna synthetases for reducing inflammation
|
PT105029B
(en)
*
|
2010-03-29 |
2012-09-11 |
Univ Do Minho |
NUCLEIC PEPTIDE ACID PROBE, CASE AND METHOD FOR DETECTING AND / OR QUANTIFYING SALMONELLA AND THEIR APPLICATIONS
|
AU2011237688B2
(en)
*
|
2010-04-06 |
2015-09-10 |
Dana-Faber Cancer Institute, Inc. |
Gene-expression profiling with reduced numbers of transcript measurements
|
US10619195B2
(en)
|
2010-04-06 |
2020-04-14 |
Massachusetts Institute Of Technology |
Gene-expression profiling with reduced numbers of transcript measurements
|
WO2011134084A1
(en)
|
2010-04-30 |
2011-11-03 |
Enobia Pharma Inc. |
Methods, compositions, and kits for the treatment of matrix mineralization disorders
|
US8524217B2
(en)
|
2010-05-11 |
2013-09-03 |
Merck Sharp & Dohme Corp. |
MCP1-Ig fusion variants
|
ES2717912T3
(en)
|
2010-05-14 |
2019-06-26 |
Univ Colorado Regents |
Groups targeted to complement receptor 2 (cr2) improved
|
KR20130036276A
(en)
|
2010-06-22 |
2013-04-11 |
더 리젠츠 오브 더 유니버시티 오브 콜로라도, 어 바디 코포레이트 |
Antibodies to the c3d fragment of complement component 3
|
JP6177129B2
(en)
|
2010-07-12 |
2017-08-09 |
エータイアー ファーマ, インコーポレイテッド |
Innovative discovery of therapeutic, diagnostic and antibody compositions related to protein fragments of histidyl tRNA synthetase
|
US9266939B2
(en)
|
2010-12-27 |
2016-02-23 |
Alexion Pharmaceuticals, Inc. |
Compositions comprising natriuretic peptides and methods of use thereof
|
KR20140034821A
(en)
|
2011-05-16 |
2014-03-20 |
바이엘 인텔렉쳐 프로퍼티 게엠베하 |
Use of cathepsin k inhibition for the treatment and/or prophylaxis of pulmonary hypertension and/or heart failure
|
CA2856205A1
(en)
*
|
2011-11-15 |
2013-05-23 |
Oncocyte Corporation |
Methods and compositions for the treatment and diagnosis of bladder cancer
|
US8835387B2
(en)
|
2012-02-16 |
2014-09-16 |
Atyr Pharma, Inc. |
Histidyl-tRNA synthetases for treating autoimmune and inflammatory diseases
|
WO2013167153A1
(en)
|
2012-05-09 |
2013-11-14 |
Ganymed Pharmaceuticals Ag |
Antibodies useful in cancer diagnosis
|
JP2015518829A
(en)
|
2012-05-14 |
2015-07-06 |
バイオジェン・エムエイ・インコーポレイテッドBiogen MA Inc. |
LINGO-2 antagonist for treatment of conditions involving motor neurons
|
AR091069A1
(en)
|
2012-05-18 |
2014-12-30 |
Amgen Inc |
PROTEINS OF UNION TO ANTIGEN DIRECTED AGAINST THE ST2 RECEIVER
|
US10052366B2
(en)
|
2012-05-21 |
2018-08-21 |
Alexion Pharmaceuticsl, Inc. |
Compositions comprising alkaline phosphatase and/or natriuretic peptide and methods of use thereof
|
WO2014018849A1
(en)
*
|
2012-07-26 |
2014-01-30 |
International Park Of Creativity |
Preparation of biological devices and their use thereof for increasing the production of secondary metabolites from plants
|
WO2014018822A2
(en)
|
2012-07-26 |
2014-01-30 |
Casa Luker S.A. |
Methods for increasing the production of phenolic compounds from theobroma cacao
|
US10413620B2
(en)
|
2012-08-17 |
2019-09-17 |
The Regents Of The University Of Colorado, A Body Corporate |
Light-emitting versions of the monoclonal antibody to C3D (MAB 3D29) for imaging
|
WO2014028865A1
(en)
|
2012-08-17 |
2014-02-20 |
The Regents Of The University Of Colorado, A Body Corporate |
Compositions and methods for detecting complement activation
|
ES2708565T3
(en)
|
2013-03-15 |
2019-04-10 |
Atyr Pharma Inc |
Conjugates of Fc-histidyl-tRNA synthetase
|
CN104178489B
(en)
*
|
2013-05-23 |
2017-09-19 |
安徽医科大学第一附属医院 |
AAGAB gene mutation bodies and its application
|
WO2015177744A1
(en)
*
|
2014-05-21 |
2015-11-26 |
Consiglio Nazionale Delle Ricerche |
A diagnostic marker for paget disease
|
WO2016007873A1
(en)
|
2014-07-11 |
2016-01-14 |
The Regents Of The University Of Michigan |
Compositions and methods for treating craniosynostosis
|
JP6787894B2
(en)
|
2014-12-05 |
2020-11-18 |
アレクシオン ファーマシューティカルズ, インコーポレイテッド |
Treatment of seizures with recombinant alkaline phosphatase
|
CA2973266A1
(en)
|
2015-01-08 |
2016-07-14 |
Biogen Ma Inc. |
Lingo-1 antagonists and uses for treatment of demyelinating disorders
|
AU2016211447B2
(en)
|
2015-01-28 |
2021-09-23 |
Alexion Pharmaceuticals, Inc. |
Methods of treating a subject with an alkaline phosphatase deficiency
|
KR102644116B1
(en)
|
2015-08-17 |
2024-03-05 |
알렉시온 파마슈티칼스, 인코포레이티드 |
Preparation of alkaline phosphatase
|
JP6868617B2
(en)
|
2015-09-28 |
2021-05-12 |
アレクシオン ファーマシューティカルズ, インコーポレイテッド |
Identifying effective dosing regimens for tissue-nonspecific alkaline phosphatase (TNSALP) enzyme replacement therapy for hypophosphataseemia
|
JP2018533571A
(en)
|
2015-10-30 |
2018-11-15 |
アレクシオン ファーマシューティカルズ, インコーポレイテッド |
Methods for treating cranial suture early healing disease in a patient
|
US11111279B2
(en)
|
2015-11-20 |
2021-09-07 |
Grand Valley State University |
Nato3 mutant polypeptides and uses thereof
|
WO2017155569A1
(en)
|
2016-03-08 |
2017-09-14 |
Alexion Pharmaceuticals, Inc. |
Methods for treating hypophosphatasia in children
|
US10898549B2
(en)
|
2016-04-01 |
2021-01-26 |
Alexion Pharmaceuticals, Inc. |
Methods for treating hypophosphatasia in adolescents and adults
|
WO2017173413A1
(en)
|
2016-04-01 |
2017-10-05 |
Alexion Pharmaceuticals, Inc. |
Treating muscle weakness with alkaline phosphatases
|
WO2017214130A1
(en)
|
2016-06-06 |
2017-12-14 |
Alexion Pharmaceuticals, Inc. |
Metal impact on manufacturing of alkaline phosphatases
|
WO2018035420A1
(en)
|
2016-08-18 |
2018-02-22 |
Alexion Pharmaceuticals, Inc. |
Methods for treating tracheobronchomalacia
|
CN110719786A
(en)
|
2017-03-31 |
2020-01-21 |
阿雷克森制药公司 |
Methods for treating Hypophosphatasia (HPP) in adults and adolescents
|
WO2018195338A1
(en)
|
2017-04-20 |
2018-10-25 |
Atyr Pharma, Inc. |
Compositions and methods for treating lung inflammation
|
WO2019036484A1
(en)
*
|
2017-08-15 |
2019-02-21 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for treatment of argininosuccinic aciduria
|
CN110172462B
(en)
*
|
2017-08-20 |
2021-11-30 |
浙江大学 |
Gene with promotion effect on generation and development of tumor, expression product and application thereof
|
JP2021519590A
(en)
|
2018-03-30 |
2021-08-12 |
アレクシオン ファーマシューティカルズ, インコーポレイテッド |
Glycoprotein production
|